Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.
We are a privately held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.
310 E 67th St, Suite 1-12 New York, NY
(646) 856-9261
info@rgenix.com